Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,608 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation.
Boy M, Bisio V, Zhao LP, Guidez F, Schell B, Lereclus E, Henry G, Villemonteix J, Rodrigues-Lima F, Gagne K, Retiere C, Larcher L, Kim R, Clappier E, Sebert M, Mekinian A, Fain O, Caignard A, Espeli M, Balabanian K, Toubert A, Fenaux P, Ades L, Dulphy N. Boy M, et al. Among authors: kim r. Nat Commun. 2023 Feb 3;14(1):588. doi: 10.1038/s41467-023-36193-w. Nat Commun. 2023. PMID: 36737440 Free PMC article.
Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy.
Cerrano M, Duchmann M, Kim R, Vasseur L, Hirsch P, Thomas X, Quentin S, Pasanisi J, Passet M, Rabian F, Rahmé R, Lengliné E, Raffoux E, Dhédin N, Sébert M, Maarek O, Raimbault A, Celli-Lebras K, Adès L, Fenaux P, Boissel N, Delhommeau F, Soulier J, Dombret H, Clappier E, Sujobert P, Itzykson R. Cerrano M, et al. Among authors: kim r. Leukemia. 2021 Mar;35(3):712-723. doi: 10.1038/s41375-020-0932-8. Epub 2020 Jun 24. Leukemia. 2021. PMID: 32581253
Prevalence of UBA1 mutations in MDS/CMML patients with systemic inflammatory and auto-immune disease.
Zhao LP, Schell B, Sébert M, Kim R, Lemaire P, Boy M, Mathis S, Larcher L, Chauvel C, Dhouaieb MB, Bisio V, Preudhomme C, Marceau-Renaut A, Itzykson R, Mekinian A, Fain O, Toubert A, Fenaux P, Dulphy N, Clappier E, Adès L. Zhao LP, et al. Among authors: kim r. Leukemia. 2021 Sep;35(9):2731-2733. doi: 10.1038/s41375-021-01353-8. Epub 2021 Aug 3. Leukemia. 2021. PMID: 34344988 No abstract available.
UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome.
Zakine E, Schell B, Battistella M, Vignon-Pennamen MD, Chasset F, Mahévas T, Cordoliani F, Adès L, Sébert M, Delaleu J, Jachiet M, Lepelletier C, Lemaire P, Chauvel C, Dhouaieb B, Kim R, Cassius C, Georgin-Lavialle S, Mekinian A, Bagot M, Braun T, Rousset L, Begon E, de Masson A, Fenaux P, Clappier E, Bouaziz JD. Zakine E, et al. Among authors: kim r. JAMA Dermatol. 2021 Nov 1;157(11):1349-1354. doi: 10.1001/jamadermatol.2021.3344. JAMA Dermatol. 2021. PMID: 34495287 Free PMC article.
Ikaros deficiency is associated with aggressive BCR-ABL1 B-cell precursor acute lymphoblastic leukemia independent of the lineage and developmental origin.
Simand C, Keime C, Cayé A, Arfeuille C, Passet M, Kim R, Cavé H, Clappier E, Kastner P, Chan S, Heizmann B. Simand C, et al. Among authors: kim r. Haematologica. 2022 Jan 1;107(1):316-320. doi: 10.3324/haematol.2021.279125. Haematologica. 2022. PMID: 34587720 Free PMC article. No abstract available.
Clinical, pathological, and molecular features of myelodysplasia cutis.
Delaleu J, Kim R, Zhao LP, de Masson A, Vignon-Pennamen MD, Cassius C, Ram-Wolff C, Bagot M, Clappier E, Adès L, Sebert M, Bouaziz JD, Fenaux P, Battistella M. Delaleu J, et al. Among authors: kim r. Blood. 2022 Feb 24;139(8):1251-1253. doi: 10.1182/blood.2021013967. Blood. 2022. PMID: 34788403 Free article. No abstract available.
Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL.
Passet M, Kim R, Gachet S, Sigaux F, Chaumeil J, Galland A, Sexton T, Quentin S, Hernandez L, Larcher L, Bergugnat H, Ye T, Karasu N, Caye A, Heizmann B, Duluc I, Chevallier P, Rousselot P, Huguet F, Leguay T, Hunault M, Pflumio F, Freund JN, Lobry C, Lhéritier V, Dombret H, Domon-Dell C, Soulier J, Boissel N, Clappier E. Passet M, et al. Among authors: kim r. Blood. 2022 Jun 16;139(24):3505-3518. doi: 10.1182/blood.2021014723. Blood. 2022. PMID: 35316324 Free PMC article.
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study.
Duployez N, Largeaud L, Duchmann M, Kim R, Rieunier J, Lambert J, Bidet A, Larcher L, Lemoine J, Delhommeau F, Hirsch P, Fenwarth L, Kosmider O, Decroocq J, Bouvier A, Le Bris Y, Ochmann M, Santagostino A, Adès L, Fenaux P, Thomas X, Micol JB, Gardin C, Itzykson R, Soulier J, Clappier E, Recher C, Preudhomme C, Pigneux A, Dombret H, Delabesse E, Sébert M. Duployez N, et al. Among authors: kim r. Blood. 2022 Aug 18;140(7):756-768. doi: 10.1182/blood.2021015328. Blood. 2022. PMID: 35443031 Free PMC article.
A multiparametric niche-like drug screening platform in acute myeloid leukemia.
Dal Bello R, Pasanisi J, Joudinaud R, Duchmann M, Pardieu B, Ayaka P, Di Feo G, Sodaro G, Chauvel C, Kim R, Vasseur L, Chat L, Ling F, Pacchiardi K, Vaganay C, Berrou J, Benaksas C, Boissel N, Braun T, Preudhomme C, Dombret H, Raffoux E, Fenouille N, Clappier E, Adès L, Puissant A, Itzykson R. Dal Bello R, et al. Among authors: kim r. Blood Cancer J. 2022 Jun 24;12(6):95. doi: 10.1038/s41408-022-00689-3. Blood Cancer J. 2022. PMID: 35750691 Free PMC article.
Clonal evolution in hereditary thrombocytosis with MPL T487A mutation.
Vasseur L, Favier R, Kim R, Rabian F, Cabannes-Hamy A, Cassinat B, Maslah N, Vasquez N, Clappier E, Kiladjian JJ, Boissel N. Vasseur L, et al. Among authors: kim r. Pediatr Blood Cancer. 2023 Feb;70(2):e29905. doi: 10.1002/pbc.29905. Epub 2022 Aug 4. Pediatr Blood Cancer. 2023. PMID: 35924408 No abstract available.
4,608 results